Research Studies

Clinical Studies Utilizing Bio-Tech Pharmacal Products

Below is a list of some Completed Clinical Studies utilizing Bio-Tech Pharmacal products. However, various other clinical studies are being conducted but have not been completed and published yet.

Study Information	Institutions and Investigators
1. Bio-Tech D3-50,000 IU	The Kidney Institute, University of Kansas Medical Center Jason R. Stubbs – Principal Investigator
2. Bio-Tech D3-1,000 IU and 50,000 IU	University of Rochester Medical Center Peppone L.J., Huston A.J., Reid M.E., Rosier R.N., Zakharia Y., Trump D.L., Mustian K.M., Janelsins M.C., Purnell J.Q., Morrow G.R.
3. Bio-Tech D3-50,000 IU and 1000 IU	Georgia Health Sciences University Yanbin Dong, M.D., Ph.D. – Study Director Jennifer Pedersen-White, D.O.
4. Bio-Tech D3-5,000 IU	University of Minnesota – Clinical and Translational Science Institute; Minneapolis Medical Research Foundation Cary Mariash, M.D. – Study Director Shaban Nazarian, M.D. – Principal Investigator Sidney Jones, M.D. – Study Chair
5. Bio-Tech D3-50,000 IU	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); Medical College of Wisconsin Multi-site study Peter L. Havens, M.S., M.D. – Study Chair
6. Bio-Tech D3-50,000 IU and 1000 IU	Georgia Health Sciences University Yanbin Dong, M.D., Ph.D. – Study Director Jennifer Pedersen-White, D.O.
7. Bio-Tech D3-50,000 IU	Emory University Divisions of Nephrology and Cardiology Haimanot Wasse, M.D. – Principal Investigator
8. Bio-Tech D3-50,000 IU	Medical College of Wisconsin; University of California at San Francisco; St. Jude Children’s Research Hospital; United States Department of Agriculture Human Nutrition Research Center; University of South Florida College of Medicine; University of Alabama at Birmingham Peter L. Havens, M.S., M.D. – Study Chair
9. Bio-Tech D3-2,500 IU	National Institute on Aging (NIA); Rutgers University Sue Shapses, Ph.D., R.D. – Principal Investigator Stephen Schneider, M.D. Robert Brolin, M.D.
10. Bio-Tech D3-5000 IU	Cystic Fibrosis Therapeutics Foundation; University of North Carolina School of Medicine; FDA Office of Orphan Products Development Robert Aris, M.D. – Study Chair
11. Bio-Tech D3-50,000 IU	University Hospital Case Medical Center Rebecca S. Boxer, M.D. – Principal Investigator
12. Bio-Tech D3-2000 IU and 4000 IU	National Institute of Allergy and Infectious Diseases (NIAID); Autoimmunity Centers of Excellence; Feinstein Institute for Medical Research; Medical University of South Carolina Multi-site study Cynthia Aranow, M.D. – Study Chair Diane Karmen, M.D. – Study Chair
13. Bio-Tech D3-4000 IU	National Institute of Allergy and Infectious Diseases (NIAID); Food and Drug Administration (FDA); National Jewish Health; University of California, San Diego; Oregon Health and Science University Richard Gallo, M.D., Ph.D. – Study Chair
14. Bio-Tech D3-50,000 IU	Charles Drew University of Medicine and Science Morehouse School of Medicine David Martins, M.D. Naureen Tareen, M.D.
15. Bio-Tech D3-50,000 IU	Emory Global Health Institute; Republic of Georgia National Tuberculosis Program; National Center of Tuberculosis and Lung Diseases; Rollins School of Public Health Thomas R. Ziegler, M.D. – Principal Investigator
16. Bio-Tech D3-1000 IU and 50,000 IU	University of Chicago Jayant M. Pinto, M.D. – Principal Investigator
17. Bio-Tech D3-4000 IU	University of Kansas Medical Center Leigh M. Eck, M.D. – Principal Investigator Candice Rose, M.D. Leland Graves III, M.D. Barbara P. Lukert, M.D.
18. Bio-Tech D3-50,000 IU	Memorial Sloan-Kettering Cancer Center Kathleen Wesa, M.D. – Principal Investigator Barrie Cassileth, Ph.D.
19. Bio-Tech D3-5000 IU and 50,000 IU	Mayo Clinic Bernard R. Lee, Pharm.D. – Principal Investigator Thomas D. Thacher, M.D. – Principal Investigator Michael E. Meekins, Pharm.D. – Study Director
20. Bio-Tech D3-4000 IU	The University of Chicago Medical Center Robert Naclerio, M.D. – Principal Investigator
21. Bio-Tech D3-50,000 IU	Mount Sinai School of Medicine; National Kidney Foundation Peter Heeger, M.D. – Principal Investigator Anita Mehrotra, M.D. – Study Director
22. Bio-Tech D3-1000 IU	Jewish Home, San Francisco; National Institute on Aging (NIA) Janice B. Schwartz, M.D. – Principal Investigator
23. Bio-Tech D3-1000 IU and 50,000 IU	University of Michigan Medical Center Barry E. Bleske, Pharm. D. – Principal Investigator
24. Bio-Tech D3-50,000 IU and 4000 IU	National Heart, Lung, and Blood Institute (NHLBI) AsthmaNet; Pennsylvania State University College of Medicine David T. Mauger, Ph.D. – Principal Investigator
25. Bio-Tech D3-1000 IU and 5000 IU	Children’s Hospital of Philadelphia; Division of Endocrinology/Diabetes Sheela N. Magge, M.D. – Principal Investigator
26. Bio-Tech D3-50,000 IU	Tufts University; Jean Mayer USDA Human Nutrition Research Center on Aging Bess Dawson-Hughes, M.D. – Principal Investigator
27. Bio-Tech D3-50,000 IU	University of Wisconsin, Madison; University of Alabama at Birmingham; University of Rochester University of Minnesota – Clinical and Translational Science Institute; Lahey Clinic; Urology San AntonioJoel W. Slaton, M.D. – Principal Investigator
28. Bio-Tech D3-50,000 IU	University of Rochester Cancer Center Luke J. Peppone, Ph.D. – Principal Investigator
29. Bio-Tech D3-5000 IU and 50,000 IU	Department of Veterans Affairs , VA Medical Center – BronxJames B. Post, M.D. – Principal Investigator
30. Bio-Tech D3- 50,000 IU	University Hospitals Case Medical Center, Cleveland Clinic, Case Comprehensive Cancer Center Smitha Krishnamurthi, M.D. – Principal Investigator
31. Bio-Tech D3- 50,000 IU	Ohio State University, Division of Infectious Diseases Abigail Norris Turner, Ph.D. – Principal Investigator
32. Bio-Tech D3-5000 IU and 50,000 IU	Mayo Clinic Thomas D. Thacher, M.D. – Principal Investigator
33. Bio-Tech D3-5000 IU and 50,000 IU	Medical College of Georgia Yanbin Dong, M.D., Ph.D.
34. Bio-Tech D3-4000 IU	Florida International University – Human Nutrition Laboratory Fatma E. Huffman, Ph.D. – Principal Investigator
35. Bio-Tech D3-1000 IU	Pennington Biomedical Research Center – Baton Rouge, Louisiana Alok K. Gupta, M.D. – Principal Investigator
36. Bio-Tech D3-50,000 IU	The Kidney Institute, University of Kansas Medical Center Jason R. Stubbs – Principal Investigator
37. Bio-Tech D3-50,000 IU	University of Arizona Clara Curiel, M.D. – Principal Investigator
38. Bio-Tech D3-5,000 IU	International Heart Institute of Montana Saint Patrick Hospital and Health Sciences CenterBradley Berry, M.D. – Principal Investigator Heidi Moretti, M.S., R.D.
39. Bio-Tech D3-50,000 IU	Emory University, Cystic Fibrosis Foundation Multi-site studyVin Tangpricha, M.D., Ph.D . – Principal Investigator
40. Bio-Tech Vitamin K1 (5 mg)	Queens University and Kingston General Hospital Ontario, Canada Rachel Holden, M.D. – Principal Investigator
41. Bio-Tech D3-50,000 IU	Massachusetts General Hospital Sadeq A. Quraishi, M.D. – Principal Investigator
42. Bio-Tech D3-50,000, 5000, 1000 IU	Albert Einstein College of Medicine and The Children’s Hospital at Montefiore Hina J. Talib, M.D., Tulasi Ponnapakkam, Ph.D., Robert Gensure, M.D., Unab I. Khan, M.D., Ping Zhou, M.D., Susan M. Coupey, M.D.